XML 32 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities      
Net income $ 722.2 $ 583.6 $ 569.5
Adjustments to reconcile net income to cash provided by operating activities:      
Depreciation and amortization 77.4 81.9 71.2
Stock-based compensation (Notes 2 and 13) 71.0 61.6 56.9
Excess tax benefit from stock plans 0.0 0.0 (64.3)
Impairment charges (Note 4) 118.8 31.0 0.0
Change in fair value of contingent consideration liabilities (5.7) (9.9) 1.1
Deferred income taxes (27.3) 17.8 (37.4)
Purchased in-process research and development 0.0 6.7 34.5
Other 13.0 (6.2) 7.9
Changes in operating assets and liabilities:      
Accounts and other receivables, net (28.7) (27.8) (60.4)
Inventories (65.7) (124.0) (65.6)
Accounts payable and accrued liabilities 192.5 93.8 77.7
Income taxes (157.8) 293.7 105.1
Prepaid expenses and other current assets 15.7 (9.9) (12.6)
Other 1.4 8.4 20.8
Net cash provided by operating activities 926.8 1,000.7 704.4
Cash flows from investing activities      
Capital expenditures (238.7) (168.1) (176.1)
Deposit of cash in escrow 0.0 (25.0) 0.0
Purchases of held-to-maturity investments (Note 6) (210.0) (804.9) (594.7)
Proceeds from held-to-maturity investments (Note 6) 578.1 654.7 852.5
Purchases of available-for-sale investments (Note 6) (249.3) (529.8) (470.4)
Proceeds from available-for-sale investments (Note 6) 223.2 448.7 232.6
Investments in unconsolidated affiliates (Note 6) (6.6) 0.0 (7.6)
Proceeds from unconsolidated affiliates (Note 6) 0.4 8.3 1.9
Investments in trading securities, net (12.6) (12.7) (9.8)
Payment of contingent consideration (10.0) 0.0 0.0
Acquisitions (Notes 7 and 8) 0.0 (192.9) 0.0
Issuances of notes receivable 0.0 (18.9) 0.0
Investments in intangible assets and in-process research and development (3.0) (7.4) (41.3)
Other 5.2 0.8 1.2
Net cash provided by (used in) investing activities 76.7 (647.2) (211.7)
Cash flows from financing activities      
Proceeds from issuance of debt 688.0 994.7 253.5
Payments on debt and capital lease obligations (1,125.3) (818.4) (31.4)
Purchases of treasury stock (795.5) (763.3) (662.3)
Proceeds from stock plans 147.0 113.8 103.3
Payment of contingent consideration (15.1) 0.0 0.0
Excess tax benefit from stock plans 0.0 0.0 64.3
Other (0.3) 0.0 4.1
Net cash used in financing activities (1,101.2) (473.2) (268.5)
Effect of currency exchange rate changes on cash and cash equivalents (6.5) 7.9 (12.5)
Net (decrease) increase in cash and cash equivalents (104.2) (111.8) 211.7
Cash and cash equivalents at beginning of year 818.3 930.1 718.4
Cash and cash equivalents at end of year $ 714.1 $ 818.3 $ 930.1